Organización Sanitaria Integrada Goierri-Urola Garaia

2024

1. Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD study

   Alzheimer's and Dementia

2. Blood-based multivariate methylation risk score for cognitive impairment and dementia

   Alzheimer's and Dementia

3. CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease

   Alzheimer's and Dementia

4. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

   Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 16, Núm. 2

5. GOIZ ZAINDU study: a FINGER-like multidomain lifestyle intervention feasibility randomized trial to prevent dementia in Southern Europe

   Alzheimer's Research and Therapy, Vol. 16, Núm. 1

6. Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study

   Brain Communications, Vol. 6, Núm. 4

7. Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies

   Fluids and Barriers of the CNS, Vol. 21, Núm. 1

8. Kognitiboki hauskorrak diren pertsonengan narriadura kognitiboa eta dementzia prebenitzeko esku-hartze kognitibo eta sozioemozional baten proposamena: “GOIZ ZAINDU”-tik “CITA GO-ON”-era

   Osagaiz: osasun-zientzien aldizkaria, Vol. 8, Núm. 1, pp. 91-101

9. Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study

   Journal of Alzheimer's Disease, Vol. 100, Núm. s1, pp. S187-S196

10. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results

    Alzheimer's and Dementia, Vol. 20, Núm. 5, pp. 3525-3542

11. Unlocking Preclinical Alzheimer’s: A Multi-Year Label-Free In Vitro Raman Spectroscopy Study Empowered by Chemometrics

    International Journal of Molecular Sciences, Vol. 25, Núm. 9